← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1985Last known activity
Dec 1, 2025
Timeline
1980s
- Jan 1, 1985
Geisinger Clinic— Founded
Drugs by trial phase (31 distinct, 23 trials)
Phase 4 (15 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (9 own, 0 via acquisition)
Indications
Studied for
- Acute Pain
- Cardiovascular Diseases
- Cluster Headache
- Coronary Disease
- Death, Sudden
- Death, Sudden, Cardiac
- Diabetes Mellitus, Type 2
- Femoral Fractures
- Fractures, Bone
- Fragile X Syndrome
- Glioblastoma
- Headache
- Head and Neck Neoplasms
- Heart Diseases
- Myocardial Infarction
- Myocardial Ischemia
- Radius Fractures
- Surgical Wound Infection
- Syndrome
- Vasospasm, Intracranial
- Ventricular Fibrillation
Recent trials (50)
- NCT06936709Lead sponsorPhase 4Dec 1, 2025
- NCT06936709Sponsor investigatorPhase 4Dec 1, 2025
- NCT05890898Lead sponsorN/ASep 19, 2023
- NCT05464615Lead sponsorEarly Phase 1Aug 1, 2022
- NCT05464615Overall official - principal investigatorEarly Phase 1Aug 1, 2022
- NCT05464615Reponsible party - principal investigatorEarly Phase 1Aug 1, 2022
- NCT04863222Lead sponsorPhase 4Nov 12, 2021
- NCT04863222Overall official - principal investigatorPhase 4Nov 12, 2021
- NCT04741074Lead sponsorPhase 3Jul 23, 2021
- NCT04741074Reponsible party - principal investigatorPhase 3Jul 23, 2021
- NCT04741074Overall official - principal investigatorPhase 3Jul 23, 2021
- NCT04626141Lead sponsorPhase 4Jan 31, 2021
- NCT04626141Sponsor investigatorPhase 4Jan 31, 2021
- NCT04626141Overall official - principal investigatorPhase 4Jan 31, 2021
- NCT04624672Lead sponsorPhase 4Dec 31, 2020
Details
- Founded
- Pennsylvania, NJ, US Jan 1, 1985
- Last known activity
- Dec 1, 2025